Back to company

BOOST Pharma ApS: Financial statements 2025

CVR: 41120495

BOOST Pharma ApS (CVR 41120495) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -7,557,572 and a net result of DKK -9,243,488 compared with DKK -4,259,583 the year before. Equity amounted to DKK -11,850,535. The company had 2 employees in the financial year.

Gross Profit
-7,557,572 kr.
Profit/Loss
-9,243,488 kr.
Equity
-11,850,535 kr.
Total Assets
7,206,920 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--7.6 mio.-9.2 mio.-11.9 mio.2
2024--2.2 mio.-4.3 mio.-7 mio.2
2023--1.5 mio.-2.8 mio.-9.2 mio.1
2022--3.5 mio.-4.2 mio.-6.4 mio.1
2021--1.3 mio.-2.2 mio.-2.2 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like BOOST Pharma ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

Registered as owner of BOOST Pharma ApSOct 30, 2025

As of October 30, 2025, is registered as an owner of BOOST Pharma ApS with an ownership share of 100%.

Hans Thalsgård Schambye joins the board of BOOST Pharma ApSAug 22, 2025

As of August 22, 2025, Hans Thalsgård Schambye has joined the board of directors of BOOST Pharma ApS.

BOOST Pharma ApS: The 2024 annual report is outMay 26, 2025

BOOST Pharma ApS has published its annual report for 2024. Gross profit came to DKK -2,193,394, and the net result was DKK -4,259,583.

About BOOST Pharma ApS

BOOST Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Thalsgård Schambye. The company is owned by BOOST Pharma AB. In 2025, the company reported a gross profit of DKK -7,557,572 and a net result of DKK -9,243,488 compared with DKK -4,259,583 the year before. Equity amounted to DKK -11,850,535.

Other financial years